Last Price
1.22
Today's Change
-0.07 (5.42%)
Day's Change
1.19 - 1.31
Trading Volume
197,515
Market Cap
3 Million
Shares Outstanding
3 Million
Avg Volume
1,277,458
Avg Price (50 Days)
1.24
Avg Price (200 Days)
4.05
PE Ratio
-0.18
EPS
-6.89
Earnings Announcement
30-Apr-2023
Previous Close
1.29
Open
1.28
Day's Range
1.19 - 1.31
Year Range
0.921 - 20.4
Trading Volume
197,718
1 Day Change
-5.43%
5 Day Change
-8.96%
1 Month Change
2.52%
3 Month Change
-20.78%
6 Month Change
-68.72%
Ytd Change
-56.12%
1 Year Change
-93.41%
3 Year Change
74.91%
5 Year Change
74.91%
10 Year Change
74.91%
Max Change
74.91%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.